Ovarian hormones and vascular disease

Area of Science:

• Cardiovascular Science
• Endocrinology
• Women's Health

Background:

• Observational studies suggest hormone therapy (HT) benefits women starting in perimenopause/early postmenopause.
• Randomized trials in older postmenopausal women indicate potential harm from HT.
• The 'timing hypothesis' posits altered estrogen signaling with aging, converting protective to toxic vascular effects.

Purpose of the Study:

• Review recent literature on age-dependent effects of estrogen on the female vasculature.
• Investigate the fundamental cellular and molecular mechanisms behind these age-dependent effects.
• Clarify the paradoxical findings regarding HT in different menopausal stages.

Main Methods:

• Literature review of observational and randomized controlled trials.
• Analysis of mechanistic studies on estrogen's vascular effects.
• Focus on age-dependent cellular and molecular mechanisms.

Main Results:

• Early menopause correlates with adverse cardiovascular outcomes; early HT initiation mitigates these.
• Estrogen modulates vascular inflammation, growth factors, and oxidative stress in younger women.
• These vasoprotective mechanisms are lost in aged women or those with prolonged estrogen deprivation.

Conclusions:

• Estrogen's vasoprotective effects are age-dependent, diminishing with aging and/or estrogen deprivation.
• Future research should focus on preserving estrogen's benefits in older women.
• Innovative strategies may improve cardiovascular health in aging women.